These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3508718)

  • 1. Effects of decreasing serum calcium on circulating parathyroid hormone and vitamin D metabolites in normocalcaemic and hypercalcaemic patients treated with APD.
    Papapoulos SE; Harinck HI; Bijvoet OL; Gleed JH; Fraher LJ; O'Riordan JL
    Bone Miner; 1986 Feb; 1(1):69-78. PubMed ID: 3508718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term elevation of 1,25-dihydroxyvitamin D after short-term intravenous administration of pamidronate (aminohydroxypropylidene bisphosphonate, APD) in Paget's disease of bone.
    Devlin RD; Retallack RW; Fenton AJ; Grill V; Gutteridge DH; Kent GN; Prince RL; Worth GK
    J Bone Miner Res; 1994 Jan; 9(1):81-5. PubMed ID: 8154313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overproduction of an amino-terminal form of PTH distinct from human PTH(1-84) in a case of severe primary hyperparathyroidism: influence of medical treatment and surgery.
    Räkel A; Brossard JH; Patenaude JV; Albert C; Nassif E; Cantor T; Rousseau L; D'Amour P
    Clin Endocrinol (Oxf); 2005 Jun; 62(6):721-7. PubMed ID: 15943835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in vitamin D metabolites during treatment of Paget's disease of bone with calcitonin or etidronate.
    Devlin RD; Gutteridge DH; Prince RL; Retallack RW; Worth GK
    J Bone Miner Res; 1990 Nov; 5(11):1121-6. PubMed ID: 2125401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of recombinant PTH(1-34) and PTH(1-84) on serum ionized calcium, 1,25-dihydroxyvitamin D, and urinary calcium excretion: a pilot study.
    Piemonte S; Romagnoli E; Cipriani C; Fassino V; Del Fiacco R; Carnevale V; Scillitani A; D'Erasmo E; Tancredi A; Minisola S
    Calcif Tissue Int; 2009 Oct; 85(4):287-92. PubMed ID: 19756348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of calcium and 1,25 dihydroxyvitamin D on the level of parathyroid hormone in patients with secondary hyperparathyroidism due to chronic renal insufficiency.
    Vucković S; Paunković N
    Med Pregl; 1993; 46 Suppl 1():40-2. PubMed ID: 8569602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of perioperative factors predicting hypocalcemia after thyroid and parathyroid surgery.
    Chia SH; Weisman RA; Tieu D; Kelly C; Dillmann WH; Orloff LA
    Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):41-5. PubMed ID: 16415428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyroid hormone changes during phosphorus load in patients with chronic renal insufficiency with low serum parathyroid hormone or adynamic bone disease.
    Cuppari L; Carvalho AB; Lobão RR; Martini LA; Cendoroglo M; Ventura RT; Draibe SA
    Clin Nephrol; 2001 Jul; 56(1):35-43. PubMed ID: 11499657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D metabolites do not alter parathyroid hormone secretion acutely.
    Magliola L; Anast CS; Forte LR
    Bone Miner; 1986 Dec; 1(6):495-505. PubMed ID: 3509783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct and indirect assessment of the parathyroid hormone response to pamidronate therapy in Paget's disease of bone and hypercalcaemia of malignancy.
    Fraser WD; Logue FC; Gallacher SJ; O'Reilly DS; Beastall GH; Ralston SH; Boyle IT
    Bone Miner; 1991 Feb; 12(2):113-21. PubMed ID: 1849762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increases in parathyroid hormone (PTH) after gastric bypass surgery appear to be of a secondary nature.
    Jin J; Robinson AV; Hallowell PT; Jasper JJ; Stellato TA; Wilhem SM
    Surgery; 2007 Dec; 142(6):914-20; discussion 914-20. PubMed ID: 18063076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating PTH and PTHrP levels before and after treatment of tumor induced hypercalcemia with Pamidronate Disodium (APD).
    Grill V; Murray RM; Ho PW; Santamaria JD; Pitt P; Potts C; Jerums G; Martin TJ
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1468-70. PubMed ID: 1592895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6 and the acute phase response during treatment of patients with Paget's disease with the nitrogen-containing bisphosphonate dimethylaminohydroxypropylidene bisphosphonate.
    Schweitzer DH; Oostendorp-van de Ruit M; Van der Pluijm G; Löwik CW; Papapoulos SE
    J Bone Miner Res; 1995 Jun; 10(6):956-62. PubMed ID: 7572320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of parathyroid hormone and vitamin D in essential hypertension.
    Young EW; Morris CD; Holcomb S; McMillan G; McCarron DA
    Am J Hypertens; 1995 Oct; 8(10 Pt 1):957-64. PubMed ID: 8845076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with elevated serum parathyroid hormone levels after parathyroidectomy: showing signs of decreased peripheral parathyroid hormone sensitivity.
    Nordenström E; Westerdahl J; Isaksson A; Lindblom P; Bergenfelz A
    World J Surg; 2003 Feb; 27(2):212-5. PubMed ID: 12616439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of vitamin D replacement in patients with normocalcaemic and hypercalcaemic primary hyperparathyroidism and coexisting vitamin D deficiency.
    Das G; Eligar V; Govindan J; Bondugulapati LN; Okosieme O; Davies S
    Ann Clin Biochem; 2015 Jul; 52(Pt 4):462-9. PubMed ID: 25468998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paget's disease of bone and calcium homeostasis: focus on bisphosphonate treatment.
    Polyzos SA; Anastasilakis AD; Makras P; Terpos E
    Exp Clin Endocrinol Diabetes; 2011 Oct; 119(9):519-24. PubMed ID: 21811962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of calcium absorption by 1,25,dihydroxy-vitamin D--studies of the effects of a bisphosphonate treatment.
    Adami S; Frijlink WB; Bijvoet OL; O'Riordan JL; Clemens TL; Papapoulos SE
    Calcif Tissue Int; 1982 Jul; 34(4):317-20. PubMed ID: 6814718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A survey of diagnoses in patients with a low intact parathyroid hormone concentration.
    Manning EM; Fraser WD
    Ann Clin Biochem; 1993 May; 30 ( Pt 3)():252-5. PubMed ID: 8517606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.